First Command Advisory Services, Inc. Arcutis Biotherapeutics, Inc. Put Options Transaction History
First Command Advisory Services, Inc.
- $13.7 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ARQT
# of Institutions
247Shares Held
132MCall Options Held
407KPut Options Held
216K-
Jennison Associates LLC12.3MShares$303 Million0.14% of portfolio
-
Suvretta Capital Management, LLC New York, NY11.5MShares$286 Million5.56% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$266 Million3.47% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA9.87MShares$244 Million7.3% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$213 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $1.49B
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...